Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Factor plasma concentration

The plasma clearance of theophylline varies widely. Theophylline is metabolized by the liver, so typical doses may lead to toxic concentrations of the drug in patients with liver disease. Conversely, clearance may be increased through the induction of hepatic enzymes by cigarette smoking or by changes in diet. In normal adults, the mean plasma clearance is 0.69 mL/kg/min. Children clear theophylline faster than adults (1-1.5 mL/kg/min). Neonates and young infants have the slowest clearance (see Chapter 59). Even when maintenance doses are altered to correct for the above factors, plasma concentrations vary widely. [Pg.435]

Affinity chromatography is used in the preparation of more highly purified Factor IX concentrates (53—55) as well as in the preparation of products such as antithrombin III [9000-94-6] (56,57). Heparin [9005-49-6], a sulfated polysaccharide (58), is the ligand used most commonly in these appHcations because it possesses specific binding sites for a number of plasma proteins (59,60). [Pg.529]

Fig. 6. Share of U.S. market occupied by human albumin/plasma protein fraction, (—) Factor VIII concentrate, (-) intravenous immunoglobulin... Fig. 6. Share of U.S. market occupied by human albumin/plasma protein fraction, (—) Factor VIII concentrate, (-) intravenous immunoglobulin...
Ciraulo DA, Sands BE, Shader RI Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145 1501-1506, 1988b Ciraulo DA, Barnhill JG, Ciraulo AM, et al Parental alcoholism as a risk factor in benzodiazepine abuse a pilot smdy. Am J Psychiatry 146 1333-1335, 1989 Ciraulo DA, Antal EJ, Smith RB, et al The relationship of alprazolam dose to steady-state plasma concentrations. J Clin Psychopharmacol 10 27—32, 1990 Ciraulo DA, Sarid-Segal O, Knapp C, et al Liability to alprazolam abuse in daughters of alcoholics. Am J Psychiatry 153 956-958, 1996 Ciraulo DA, Barnhill JG, Ciraulo AM, et al Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone. J Clin Pharmacol 37 64-73, 1997... [Pg.150]

In past years, treatment for patients with hemophilia A has consisted of administration of cryoprecipitates (enriched in factor VIII) prepared from individual donors or lyophilized factor VIII concentrates prepared from plasma pools of up to 5000 donors. It is now possible to prepare factor Vlll by recombinant DNA technology. Such preparations are free of contaminating viruses (eg, hepatitis A, B, G, or HlV-1) found in human plasma but are at present expensive their use may increase if cost of production decreases. [Pg.604]

The incidence of torsades de pointes in the population at large is unknown. The incidence of torsades de pointes associated with specific drugs ranges from less than 1% to as high as 8% to 10%, depending on dose and plasma concentration of the drug and the presence of other risk factors for the arrhythmia. [Pg.128]

Type 1 patients unresponsive to desmopressin, patients with types 2 and 3 von Willebrand s disease, and major surgery patients require replacement therapy with plasma-derived intermediate- and high-purity factor VIII virus-inactivated factor VIII concentrates containing von Willebrand factor. [Pg.987]

Factor IX Replacement Hemophilia B therapy may include recombinant (produced via transfection of mammalian cells with the human factor IX gene) or plasma-derived (concentrate from pooled plasma) factor IX (see Table 64-2). Guidelines for choosing the factor-concentrate formulation for hemophilia B are similar to the guidelines for hemophilia A. However, older-generation factor IX concentrates containing other vitamin K-dependent proteins (e.g., factors II, VII, and IX), called prothrombin complex concentrates (PCCs), have been associated with thrombogenic side effects. Consequently, these products are not first-line treatment for hemophilia B.11... [Pg.990]

Factor VIII concentrates Alphanate Plasma Solvent detergent, dry heat Albumin, heparin, vWF... [Pg.990]

Factor IX concentrates AlphaNine SD domain deleted Plasma Solvent detergent, filtered Heparin... [Pg.990]

A discussion of all the reasons for this phenomenon is beyond the scope of this chapter, but a simple example will illustrate the concept. Highly lipid-soluble drugs, such as pentobarbital, are preferentially distributed into adipose tissue. The result is that plasma concentrations are extremely low after distribution is complete. When the apparent volumes of distribution are calculated, they are frequently found to exceed total body volume, occasionally by a factor of 2 or more. This would be impossible if the concentration in the entire body compartment were equal to the plasma concentration. Thus, Vd is an empirically fabricated number relating the... [Pg.83]

Stiiber, F Petersen, M., Bokelmann, F., and Schade, U A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24,381-384 (1996). [Pg.128]

Factors reported to influence TCA plasma concentrations include disease states (e.g., renal or hepatic dysfunction), genetics, age, cigarette smoking, and concurrent drug administration. Similarly, hepatic impairment, renal impairment, and age have been reported to influence the pharmacokinetics of SSRIs. [Pg.801]


See other pages where Factor plasma concentration is mentioned: [Pg.995]    [Pg.126]    [Pg.126]    [Pg.126]    [Pg.995]    [Pg.126]    [Pg.126]    [Pg.126]    [Pg.529]    [Pg.370]    [Pg.71]    [Pg.485]    [Pg.440]    [Pg.111]    [Pg.105]    [Pg.135]    [Pg.145]    [Pg.145]    [Pg.148]    [Pg.990]    [Pg.993]    [Pg.32]    [Pg.40]    [Pg.52]    [Pg.66]    [Pg.67]    [Pg.749]    [Pg.162]    [Pg.267]    [Pg.270]    [Pg.450]    [Pg.32]    [Pg.52]    [Pg.174]    [Pg.521]    [Pg.525]    [Pg.496]    [Pg.514]    [Pg.516]    [Pg.893]    [Pg.183]   
See also in sourсe #XX -- [ Pg.184 , Pg.185 ]




SEARCH



Coagulation factor VIII plasma concentration

Coagulation factor plasma concentration

Concentration factor

Factor plasma concentrations and

Hemophilia plasma-derived factor VIII concentrate

© 2024 chempedia.info